Biosimilar to Enbrel Unanimously Recommended by FDA Panel Biosimilar to Enbrel Unanimously Recommended by FDA Panel

The US Food and Drug Administration ' s Arthritis Advisory Committee unanimously recommended approval of GP2015 as a biosimilar to Enbrel (etanercept). < br / > < i > Medscape Medical News < /i >
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news